161 related articles for article (PubMed ID: 29494695)
1. Drug loss while crushing tablets: Comparison of 24 tablet crushing devices.
Thong MY; Manrique YJ; Steadman KJ
PLoS One; 2018; 13(3):e0193683. PubMed ID: 29494695
[TBL] [Abstract][Full Text] [Related]
2. Recommendations for crushing Circadin® (melatonin) tablets for safe and reliable delivery via pediatric nasogastric tubes.
Swedrowska M; Ingham S; Tomlin S; Forbes B
Int J Pharm; 2021 Feb; 594():120151. PubMed ID: 33338568
[TBL] [Abstract][Full Text] [Related]
3. Perceived Usability of Tablet Crushers: Comparison of Devices by People with and without Limited Hand Functions.
Lee SV; Aplin T; Sefidani Forough A; Steadman KJ
Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36839840
[TBL] [Abstract][Full Text] [Related]
4. [A Method for Decreasing the Amount of the Drug Remaining on the Surfaces of the Mortar and Pestle after Grinding Small Amount of Tablets].
Kawakami M; Kitada R; Kurita T; Tokumura T
Yakugaku Zasshi; 2017; 137(8):1017-1025. PubMed ID: 28768941
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of crushed ticagrelor tablet doses: recovery following crushing and naso-gastric tube passage ex vivo.
Crean B; Finnie C; Crosby A
Drugs R D; 2013 Jun; 13(2):153-7. PubMed ID: 23737454
[TBL] [Abstract][Full Text] [Related]
6. Assessment of practices for suspended oral drugs by tablet crushing in pediatric units.
Nguyen D; Secretan PH; Auvity S; Vidal F; Postaire M; Cisternino S; Schlatter J
Eur J Pharm Biopharm; 2020 Dec; 157():175-182. PubMed ID: 33222769
[TBL] [Abstract][Full Text] [Related]
7. Detrimental consequences of the paracetamol tablet elastic relaxation during ejection.
Anuar MS; Briscoe BJ
Drug Dev Ind Pharm; 2010 Aug; 36(8):972-9. PubMed ID: 20515396
[TBL] [Abstract][Full Text] [Related]
8. Stability and recovery of DIFICID(®) (Fidaxomicin) 200-mg crushed tablet preparations from three delivery vehicles, and administration of an aqueous dispersion via nasogastric tube.
Tousseeva A; Jackson JD; Redell M; Henry T; Hui M; Capurso S; DeRyke CA
Drugs R D; 2014 Dec; 14(4):309-14. PubMed ID: 25424419
[TBL] [Abstract][Full Text] [Related]
9. Solventless-mixing tablet coating technique using a V-shaped blender; investigation using methyl methacrylate and diethylaminoethyl methacrylate copolymer powder.
Kondo K; Ono K; Ueda A; Niwa T
Eur J Pharm Biopharm; 2020 Jan; 146():41-54. PubMed ID: 31786323
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of in vitro dissolution profiles of modified-release metoprolol succinate tablets crushed using mortar and pestle technique.
Kir F; Al-Sulaiti FK; Sahin S
Eur J Pharm Sci; 2024 Mar; 194():106694. PubMed ID: 38191064
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the tamper-resistant properties of biphasic immediate-release/extended-release oxycodone/acetaminophen tablets.
Eisenhauer TD; Matchett M; Heasley R; Morton T; Devarakonda K; Giuliani M; Young JL; Barrett T
Drug Dev Ind Pharm; 2016 Jan; 42(1):157-165. PubMed ID: 26146769
[TBL] [Abstract][Full Text] [Related]
12. Dose form modification - a common but potentially hazardous practice. A literature review and study of medication administration to older psychiatric inpatients.
Stubbs J; Haw C; Dickens G
Int Psychogeriatr; 2008 Jun; 20(3):616-27. PubMed ID: 17711606
[TBL] [Abstract][Full Text] [Related]
13. Crushing riluzole tablets: evaluation of loss of powder and active principle in a home-simulation experiment.
Casiraghi A; Gentile A; Marjanovic I; Chiò A
Amyotroph Lateral Scler Frontotemporal Degener; 2023 Aug; ():1-7. PubMed ID: 37584401
[No Abstract] [Full Text] [Related]
14. Performance of Tablet Splitters, Crushers, and Grinders in Relation to Personalised Medication with Tablets.
Woerdenbag HJ; Visser JC; Leferink Op Reinink MPAM; van Orsoy RR; Eissens AC; Hagedoorn P; Dijkstra H; Allersma DP; Ng SW; Smeets OSNM; Frijlink HW
Pharmaceutics; 2022 Jan; 14(2):. PubMed ID: 35214052
[TBL] [Abstract][Full Text] [Related]
15. In-line monitoring of the drug content of powder mixtures and tablets by near-infrared spectroscopy during the continuous direct compression tableting process.
Järvinen K; Hoehe W; Järvinen M; Poutiainen S; Juuti M; Borchert S
Eur J Pharm Sci; 2013 Mar; 48(4-5):680-8. PubMed ID: 23313622
[TBL] [Abstract][Full Text] [Related]
16. Impact of recommendations on crushing medications in geriatrics: from prescription to administration.
Bourdenet G; Giraud S; Artur M; Dutertre S; Dufour M; Lefèbvre-Caussin M; Proux A; Philippe S; Capet C; Fontaine-Adam M; Kadri K; Landrin I; Gréboval E; Touflet M; Nanfack J; Tharasse C; Varin R; Rémy E; Daouphars M; Doucet J
Fundam Clin Pharmacol; 2015 Jun; 29(3):316-20. PubMed ID: 25789404
[TBL] [Abstract][Full Text] [Related]
17. COMPARISON OF HYDROCORTISONE 10 MG TABLETS: TABLET HARDNESS OPTIMISED FOR ADULT USE HAS NEGATIVE CONSEQUENCES FOR PAEDIATRIC USE.
Saimbi S; Madden V; Stirling H; Yahyouche A; Batchelor H
Arch Dis Child; 2016 Sep; 101(9):e2. PubMed ID: 27540195
[TBL] [Abstract][Full Text] [Related]
18. Stability of Crushed Tedizolid Phosphate Tablets for Nasogastric Tube Administration.
Kennedy G; Osborn J; Flanagan S; Alsayed N; Bertolami S
Drugs R D; 2015 Dec; 15(4):329-33. PubMed ID: 26416654
[TBL] [Abstract][Full Text] [Related]
19. Crushed tablets: does the administration of food vehicles and thickened fluids to aid medication swallowing alter drug release?
Manrique YJ; Lee DJ; Islam F; Nissen LM; Cichero JA; Stokes JR; Steadman KJ
J Pharm Pharm Sci; 2014; 17(2):207-19. PubMed ID: 24934549
[TBL] [Abstract][Full Text] [Related]
20. Pharmaceutical and safety considerations of tablet crushing in patients undergoing enteral intubation.
Salmon D; Pont E; Chevallard H; Diouf E; Tall ML; Pivot C; Pirot F
Int J Pharm; 2013 Feb; 443(1-2):146-53. PubMed ID: 23299084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
